loadpatents
Patent applications and USPTO patent grants for Panarese; Joseph.The latest application filed is for "functionalized heterocycles as antiviral agents".
Patent | Date |
---|---|
Benzodiazepine derivatives as RSV inhibitors Grant 11,390,631 - Shook , et al. July 19, 2 | 2022-07-19 |
Functionalized heterocycles as antiviral agents Grant 11,377,450 - Panarese , et al. July 5, 2 | 2022-07-05 |
Functionalized heterocycles as antiviral agents Grant 11,198,693 - Panarese , et al. December 14, 2 | 2021-12-14 |
Heterocyclic compounds as RSV inhibitors Grant 11,091,501 - Kim , et al. August 17, 2 | 2021-08-17 |
Substituted heterocycles as antiviral agents Grant 11,058,678 - Panarese , et al. July 13, 2 | 2021-07-13 |
Functionalized Heterocycles As Antiviral Agents App 20210115060 - Panarese; Joseph ;   et al. | 2021-04-22 |
Functionalized Heterocycles As Antiviral Agents App 20210079014 - Panarese; Joseph ;   et al. | 2021-03-18 |
Processes for the preparation of benzodiazepine derivatives Grant 10,906,895 - Kim , et al. February 2, 2 | 2021-02-02 |
Substituted Heterocycles As Antiviral Agents App 20210008057 - Panarese; Joseph ;   et al. | 2021-01-14 |
Combination pharmaceutical agents as RSV inhibitors Grant 10,881,666 - Shook , et al. January 5, 2 | 2021-01-05 |
Functionalized heterocycles as antiviral agents Grant 10,865,211 - Panarese , et al. December 15, 2 | 2020-12-15 |
Benzodiazepine derivatives as RSV inhibitors Grant 10,865,215 - Shook , et al. December 15, 2 | 2020-12-15 |
Heterocyclic compounds as RSV inhibitors Grant 10,851,115 - Kim , et al. December 1, 2 | 2020-12-01 |
Heterocyclic compounds as RSV inhibitors Grant 10,759,816 - Yu , et al. Sep | 2020-09-01 |
Benzodiazepine Derivatives As Rsv Inhibitors App 20200223867 - Shook; Brian C. ;   et al. | 2020-07-16 |
Functionalized Heterocycles As Antiviral Agents App 20200165249 - Panarese; Joseph ;   et al. | 2020-05-28 |
Functionalized Heterocycles As Antiviral Agents App 20200095258 - Panarese; Joseph ;   et al. | 2020-03-26 |
Benzodiazepine derivatives as RSV inhibitors Grant 10,570,153 - Shook , et al. Feb | 2020-02-25 |
Processes For The Preparation Of Benzodiazepine Derivatives App 20190308964 - Kim; In Jong ;   et al. | 2019-10-10 |
Heteroaryldiazepine derivatives as RSV inhibitors Grant 10,398,706 - Shook , et al. Sep | 2019-09-03 |
Substituted Heterocycles As Antiviral Agents App 20190224188 - Panarese; Joseph ;   et al. | 2019-07-25 |
Processes for the preparation of benzodiazepine derivatives Grant 10,358,441 - Kim , et al. | 2019-07-23 |
Combination Pharmaceutical Agents As Rsv Inhibitors App 20190192535 - Shook; Brian C. ;   et al. | 2019-06-27 |
Heterocyclic Compounds As Rsv Inhibitors App 20190040084 - Yu; Jianming ;   et al. | 2019-02-07 |
Heterocyclic Compounds As Rsv Inhibitors App 20190002478 - Kim; In Jong ;   et al. | 2019-01-03 |
Heterocyclic Compounds As Rsv Inhibitors App 20190002479 - Kim; In Jong ;   et al. | 2019-01-03 |
Benzodiazepine Derivatives As Rsv Inhibitors App 20180258102 - Shook; Brian C. ;   et al. | 2018-09-13 |
Processes For The Preparation Of Benzodiazepine Derivatives App 20180237425 - Kim; In Jong ;   et al. | 2018-08-23 |
Heteroaryldiazepine Derivatives As Rsv Inhibitors App 20180193352 - Shook; Brian C. ;   et al. | 2018-07-12 |
Benzodiazepine derivatives as RSV inhibitors Grant 9,957,281 - Shook , et al. May 1, 2 | 2018-05-01 |
Heterocyclic Compounds As Rsv Inhibitors App 20170226129 - Yu; Jianming ;   et al. | 2017-08-10 |
Benzodiazepine Derivatives As Rsv Inhibitors App 20170022221 - Shook; Brian C. ;   et al. | 2017-01-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.